Prothrombin complex concentrate for non-vitamin K oral anticoagulant reversal: good enough for now?

Authors

  • M. Makris

    Corresponding author
    1. Department of Cardiovascular Science, University of Sheffield, Sheffield, UK
    2. Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital Sheffield, UK
    • Correspondence: Mike Makris, Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK.

      Tel.: +44 114 2712760; fax: +44 114 2756126.

      E-mail: m.makris@sheffield.ac.uk

    Search for more papers by this author

  • See also Levi M, Moore KT, Castillejos CF, Kubitza D, Berkowitz SD, Goldhaber SZ, Raghoebar M, Patel MR, Weitz JI, Levy JH. Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers. J Thromb Haemost 2014; DOI: 10.1111/jth.12599.
  • Manuscript handled by: S. Kitchen
  • Final decision: F. R. Rosendaal, 10 July 2014

No abstract is available for this article.

Ancillary